Exponent (NASDAQ:EXPO) Price Target Raised to $100.00 at Truist Financial

Exponent (NASDAQ:EXPOFree Report) had its price target increased by Truist Financial from $95.00 to $100.00 in a report released on Monday, Benzinga reports. They currently have a buy rating on the business services provider’s stock.

Separately, StockNews.com upgraded shares of Exponent from a sell rating to a hold rating in a research report on Monday, March 4th.

View Our Latest Stock Analysis on Exponent

Exponent Trading Down 2.1 %

Shares of NASDAQ:EXPO opened at $93.20 on Monday. The company has a 50 day moving average of $80.23 and a 200 day moving average of $81.85. The stock has a market cap of $4.72 billion, a P/E ratio of 47.07 and a beta of 0.68. Exponent has a 12 month low of $64.61 and a 12 month high of $102.72.

Exponent (NASDAQ:EXPOGet Free Report) last issued its quarterly earnings data on Thursday, April 25th. The business services provider reported $0.59 EPS for the quarter, beating the consensus estimate of $0.46 by $0.13. The company had revenue of $137.21 million during the quarter, compared to analysts’ expectations of $125.98 million. Exponent had a net margin of 18.72% and a return on equity of 28.13%. Exponent’s revenue for the quarter was up 6.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.56 earnings per share. On average, equities analysts forecast that Exponent will post 1.76 earnings per share for the current fiscal year.

Exponent Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, June 21st. Shareholders of record on Friday, June 7th will be given a dividend of $0.28 per share. The ex-dividend date is Friday, June 7th. This represents a $1.12 annualized dividend and a yield of 1.20%. Exponent’s payout ratio is presently 56.57%.

Insider Transactions at Exponent

In other news, insider Eric Guyer sold 3,367 shares of the business’s stock in a transaction that occurred on Friday, February 9th. The shares were sold at an average price of $78.49, for a total value of $264,275.83. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 2.20% of the company’s stock.

Institutional Investors Weigh In On Exponent

A number of hedge funds have recently made changes to their positions in EXPO. Exchange Traded Concepts LLC lifted its holdings in shares of Exponent by 1,092.5% in the 3rd quarter. Exchange Traded Concepts LLC now owns 7,453 shares of the business services provider’s stock worth $638,000 after acquiring an additional 6,828 shares during the last quarter. Raymond James & Associates raised its holdings in Exponent by 2.1% during the 3rd quarter. Raymond James & Associates now owns 484,488 shares of the business services provider’s stock valued at $41,472,000 after buying an additional 10,046 shares during the last quarter. New York State Teachers Retirement System raised its holdings in Exponent by 2.6% during the 3rd quarter. New York State Teachers Retirement System now owns 40,168 shares of the business services provider’s stock valued at $3,438,000 after buying an additional 1,020 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Exponent by 43.3% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 13,211 shares of the business services provider’s stock valued at $1,131,000 after buying an additional 3,994 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. raised its holdings in Exponent by 8.5% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 288,253 shares of the business services provider’s stock valued at $24,674,000 after buying an additional 22,559 shares during the last quarter. 92.37% of the stock is currently owned by institutional investors.

About Exponent

(Get Free Report)

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.

Further Reading

Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.